A condition previously known as polycystic ovary syndrome (PCOS) is being renamed to polyendocrine metabolic ovarian syndrome (PMOS). The name change is intended to improve care for women affected by the condition, with some reports suggesting it could impact millions of women worldwide. The renaming is seen as a significant shift that could lead to improved diagnosis, treatment, and research.